Engels Chou

Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non–Small Cell Lung Cancer in the US

Apar Kishor Ganti, Alyssa Klein, Ion Cotarla et al. · JAMA Oncology · 2021 · 764 citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Relative risk of all-cause mortality in patients with nontuberculous mycobacterial lung disease in a US managed care population

Theodore K. Marras, Christopher Vinnard, Quanwu Zhang et al. · Respiratory Medicine · 2018 · 61 citations · Full text

Public Health, Insurance, Internal Medicine +13

A global study of the unmet need for glycemic control and predictor factors among patients with type 2 diabetes mellitus who have achieved optimal fasting plasma glucose control on basal insulin

D. Raccah, Engels Chou, Stephen Colagiuri et al. · Diabetes/Metabolism Research and Reviews · 2016 · 45 citations · Full text

Medicine, Endocrinology, Internal Medicine +17

Health Care Utilization and Expenditures Following Diagnosis of Nontuberculous Mycobacterial Lung Disease in the United States

Theodore K. Marras, Mehdi Mirsaeidi, Engels Chou et al. · Journal of Managed Care & Specialty Pharmacy · 2018 · 24 citations · Full text

Medicine, Internal Medicine, Health Insurance +13

Treatment persistence after initiating basal insulin in type 2 diabetes patients: A primary care database analysis

Stefan Pscherer, Engels Chou, Franz‐Werner Dippel et al. · Primary care diabetes · 2015 · 23 citations

Medicine, Endocrinology, Internal Medicine +14